How to Reconstitute GHK-Cu: Bacteriostatic Water vs Sterile Water

What Is GHK-Cu and Why Does Reconstitution Matter?

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex first isolated from human plasma by Loren Pickart in 1973. Its reconstitution method directly affects potency, sterility, and shelf life because the lyophilized powder is hygroscopic and copper-complexed peptides show measurable degradation above pH 7.5 or under freeze-thaw stress.

The Biology Behind the Peptide

GHK-Cu is found in human plasma at concentrations near 200 ng/mL in young adults, dropping to roughly 80 ng/mL by age 60. The peptide binds copper(II) with high affinity (association constant approximately 10^15 M^-1), and this copper-binding property drives most of its studied biological effects, including modulation of collagen synthesis, antioxidant enzyme activity, and wound-healing gene expression. Research published in the journal Frontiers in Aging Neuroscience catalogued over 4,000 human genes responsive to GHK exposure in cell culture, though the clinical translation of those findings remains under active study 1.

Why Reconstitution Technique Is Not Optional

Lyophilized peptides are freeze-dried under controlled vacuum conditions specifically to extend ambient-temperature shelf life. Once you add diluent, you restart a stability clock governed by temperature, pH, and microbial load. USP General Chapter <797> (Pharmaceutical Compounding, Sterile Preparations) sets the foundational standards for beyond-use dating and sterility of reconstituted sterile preparations 2. Using the wrong diluent can shorten that clock from 28 days to a matter of hours, or introduce contamination risk across repeated draws.

Bacteriostatic Water vs Sterile Water: Which One to Use?

For any GHK-Cu vial that will be accessed more than once, bacteriostatic water is the correct diluent. Sterile water lacks a preservative, so each needle puncture of the septum risks introducing organisms that can multiply between uses.

Bacteriostatic Water (BAC Water)

Bacteriostatic water for injection, USP, contains 0.9% benzyl alcohol as a preservative. That concentration is sufficient to inhibit the growth of most common Gram-positive and Gram-negative contaminants introduced through repeated septum puncture, without causing appreciable peptide degradation at standard research concentrations 3. The FDA-approved labeling for bacteriostatic water for injection explicitly states it is "intended for use as a diluent in the preparation of parenteral products" and permits multi-dose use 4.

Key specifications for BAC water:

• Preservative: 0.9% benzyl alcohol
• pH: 4.5 to 7.0 (USP specification)
• Osmolarity: approximately 9 mOsm/L (hypotonic; becomes isotonic after peptide dissolution)
• Approved for subcutaneous, intramuscular, and intravenous use as a diluent

Sterile Water for Injection

Sterile water for injection, USP, contains no preservative. The FDA label for sterile water for injection states it is "not for multi-dose use" 5. Once the septum is punctured, the vial must be used immediately and any remainder discarded. For GHK-Cu protocols requiring repeated injections across a week, sterile water is impractical and poses a contamination risk that bacteriostatic water avoids.

The Benzyl Alcohol Safety Profile

Benzyl alcohol at 0.9% is well-tolerated in adults. The known toxicity concern (gasping syndrome) applies exclusively to neonates receiving large cumulative volumes of benzyl alcohol-preserved solutions, as documented in the FDA Drug Safety Communication and underlying case literature 6. For adult subcutaneous peptide protocols, the per-injection benzyl alcohol exposure from a 0.1 to 0.5 mL draw is negligible and well below any reported threshold for systemic toxicity.

Step-by-Step Reconstitution Protocol

Follow this sequence exactly. Deviating from aseptic technique is the most common source of contamination in compounded peptide preparations, and contaminated preparations have caused serious adverse events in documented case reports 7.

Materials Checklist

Before touching anything:

• Lyophilized GHK-Cu vial (5 mg standard)
• Bacteriostatic water for injection, USP (2 mL per 5 mg vial for standard concentration)
• Two alcohol swabs (70% isopropyl alcohol)
• One 3 mL luer-lock syringe with 23-gauge, 1-inch needle for reconstitution
• Insulin syringes for dosing draws (1 mL, 29 to 31 gauge)
• Clean, hard, non-porous surface

The Reconstitution Steps

Step 1. Wash hands for at least 20 seconds with soap and water. Allow to dry completely before handling vials.

Step 2. Swab the septum of the BAC water vial with a fresh alcohol swab. Allow 30 seconds of contact time and let the alcohol evaporate fully before inserting any needle. Residual isopropyl alcohol introduced into the vial can denature peptide bonds 8.

Step 3. Draw the desired volume of bacteriostatic water into the 3 mL syringe. For a 5 mg vial, draw 2.0 mL to yield a concentration of 2,500 mcg/mL.

Step 4. Swab the septum of the GHK-Cu vial. Allow to dry.

Step 5. Insert the needle at a 45-degree angle and direct the stream of BAC water slowly down the inner glass wall of the vial. Do not aim the stream directly at the lyophilized cake. Forcing liquid onto the cake generates foam, which introduces air-liquid interfaces that can degrade the peptide through oxidative stress at the copper center 9.

Step 6. Remove the needle and gently roll the vial between your palms for 20 to 30 seconds. Do not shake or vortex. Vigorous mechanical agitation can disrupt copper coordination bonds and accelerate the formation of aggregates, a degradation pathway documented for copper-binding peptides in pharmaceutical formulation studies 10.

Step 7. Inspect the solution. Properly reconstituted GHK-Cu should appear as a clear blue or blue-green solution, the characteristic color of the Cu(II) complex. Any visible particulate matter, cloudiness, or color change to brown or green-black indicates degradation or contamination; discard the vial.

Step 8. Label the vial with the date and time of reconstitution and the calculated concentration. Refrigerate immediately at 2 to 8 °C.

GHK-Cu Dosing Calculator: Converting Concentration to Syringe Markings

This is where most errors occur. Insulin syringes are marked in "units" (U), not milliliters, and the conversion depends on the syringe's total volume.

Understanding Insulin Syringe Markings

A standard U-100 insulin syringe holds 1 mL and is divided into 100 units. Therefore, 1 unit = 0.01 mL. At the standard reconstitution concentration of 2,500 mcg/mL:

• 1 unit on syringe = 0.01 mL = 25 mcg GHK-Cu
• 10 units on syringe = 0.10 mL = 250 mcg GHK-Cu
• 40 units on syringe = 0.40 mL = 1,000 mcg (1 mg) GHK-Cu
• 80 units on syringe = 0.80 mL = 2,000 mcg (2 mg) GHK-Cu

Adjusting for Different Concentrations

If you reconstitute with 1 mL instead of 2 mL, concentration doubles to 5,000 mcg/mL. At that concentration, 10 units on a U-100 syringe equals 500 mcg. Always recalculate when changing diluent volumes. Confusing concentrations between vials is the primary cause of dosing errors in self-administered peptide protocols, mirroring the class of error documented in insulin dosing studies 11.

Practical Dose Examples

Research protocols referenced in published wound-healing literature have used topical GHK-Cu at concentrations of 0.1%, 1% applied to wound beds, with systemic subcutaneous doses in animal studies ranging from 1 mg/kg to 5 mg/kg. Human subcutaneous injection protocols circulating in compounding pharmacy contexts typically target 1 to 2 mg per injection site, 2 to 3 times per week, though no Phase 2 or Phase 3 randomized controlled trial has established an optimal human dose for any systemic indication 12.

Syringe Selection for GHK-Cu Injection

The right syringe makes subcutaneous delivery more comfortable and reduces injection-site reactions.

Gauge and Needle Length

For subcutaneous injection, 29 to 31 gauge needles cause the least tissue trauma. A needle length of 5/16 inch (8 mm) reaches subcutaneous tissue adequately in most adults when the skin is pinched. A 2019 review of subcutaneous injection technique in the Journal of Diabetes Science and Technology confirmed that 4 to 8 mm needles are appropriate for subcutaneous delivery across varying body-composition groups 13.

Syringe Volume

Use a 1 mL (U-100) insulin syringe for all dose draws at standard concentration. Avoid 0.5 mL syringes when doses exceed 0.5 mL to prevent air-lock at the plunger. The 1 mL format also provides more readable graduation marks at the small volumes typical of peptide dosing.

Drawing the Dose

Clean the vial septum with a fresh alcohol swab before each draw. Allow to dry. Insert the needle, invert the vial, and draw to the calculated unit marking, confirming no air bubbles are pulled into the barrel. Tap and expel any air bubble before injecting.

Storage, Stability, and Beyond-Use Dating

Stability governs every decision after reconstitution.

Temperature Requirements

Store reconstituted GHK-Cu at 2 to 8 °C (standard household refrigerator range). Do not place vials near the freezer compartment or in the refrigerator door, where temperature fluctuates. Freeze-thaw cycling degrades copper-coordinated peptides through ice crystal formation and metal dissociation, a mechanism documented for analogous copper-binding compounds in formulation science 14.

Beyond-Use Date

USP <797> Category 1 (low-risk) sterile preparations prepared with commercially sterile components and immediate-use techniques carry a beyond-use date of 28 days refrigerated when a preservative (benzyl alcohol) is present. Reconstituted vials made with sterile water must be used within 24 hours or discarded, per USP guidance applied by compounding pharmacies 2.

Mark every vial clearly. A vial with no visible label is a safety hazard.

Signs of Degradation

Discard any vial showing:

• Brown, dark green, or black discoloration (copper oxidation state change)
• Cloudiness or visible particulate matter
• Unusual odor upon needle insertion
• Loss of blue-green color in solution that was previously clear blue

Copper peptide discoloration is a reliable visual marker. A 2012 stability analysis of copper-complexed peptide formulations found that color change to brown correlated with greater than 15% loss of parent compound by HPLC 15.

Topical GHK-Cu: Reconstitution Differences

Some protocols use GHK-Cu topically in a carrier solution rather than by injection.

Concentration for Topical Use

Published topical wound-healing studies have used GHK-Cu at 0.1%, 1% (w/v). A 0.1% solution equals 1 mg per mL. To make a 0.1% topical solution from a 5 mg vial, dissolve in 5 mL of sterile saline or bacteriostatic water, then mix into a topical carrier (hyaluronic acid serum, for example) at the desired ratio. The stability data for GHK-Cu in topical matrices is limited; a liposomal GHK-Cu formulation study published in International Journal of Pharmaceutics demonstrated improved skin penetration over free peptide in solution, though the clinical dose-response was not characterized in human subjects 16.

Sterility Requirements Are Lower but Still Real

Topical preparations do not require the same sterility standard as injectables. Any solution applied to broken skin, surgical wounds, or compromised barriers should be prepared under aseptic conditions using sterile components. Contaminated topical preparations applied to open wounds have caused polymicrobial infections in documented cases 7.

Safety Considerations and Regulatory Context

GHK-Cu sold for research purposes is not FDA-approved as a drug for any human indication. The FDA has flagged peptides in this class under its broader compounded drug oversight framework, and in 2023 sent warning letters to compounders marketing certain peptides outside 503A/503B frameworks 17.

Known Adverse Effects

At doses studied in human-adjacent contexts, GHK-Cu's adverse effect profile is minimal. Local injection-site redness and transient blue discoloration of skin (from the copper complex) are the most frequently reported reactions. Systemic copper toxicity from subcutaneous GHK-Cu at research doses is theoretically possible but has not been documented in the peer-reviewed literature at doses below 2 mg/kg, given that copper homeostasis is tightly regulated by ceruloplasmin and hepatic sequestration 18.

Who Should Not Use GHK-Cu

Individuals with Wilson disease (impaired copper excretion) or Menkes disease (impaired copper transport) should avoid copper-containing peptides entirely. Pregnancy and lactation represent additional contraindications given the absence of any safety data in these populations. Consult a licensed prescriber before initiating any peptide protocol.

Quick-Reference Reconstitution Table

| Vial Size | BAC Water Volume | Concentration | 1 mg Dose = | |-----------|-----------------|---------------|-------------| | 5 mg | 1.0 mL | 5,000 mcg/mL | 20 units (0.20 mL) | | 5 mg | 2.0 mL | 2,500 mcg/mL | 40 units (0.40 mL) | | 5 mg | 5.0 mL | 1,000 mcg/mL | 100 units (1.00 mL) | | 10 mg | 2.0 mL | 5,000 mcg/mL | 20 units (0.20 mL) | | 10 mg | 4.0 mL | 2,500 mcg/mL | 40 units (0.40 mL) |

All concentrations assume complete dissolution of the lyophilized cake. Confirm visually before drawing doses.